Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mattel Inc (MAT) vs Revvity Inc (RVTY) Price & Performance

Mattel IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Mattel Inc vs Revvity Inc — how do they compare? Mattel Inc trades at $14.19 (market cap $4.11B), while Revvity Inc trades at $110.1 (market cap $11.87B). The key difference: Revvity Inc is far larger — about 2.9× Mattel Inc's market cap, and Revvity Inc pays a 0.26% dividend while Mattel Inc pays none. Which is the better fit depends on your goals.

MATRVTY
Market Cap
$4.11B$11.87B
Sector
Consumer CyclicalTechnology
52-Week High
$22.16$117.75
52-Week Low
$13.05$82.26
Enterprise Value
$5.92B$14.36B
Dividend Yield
0.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mattel Inc

Mattel (MAT) trades at $14.2, down 0.7% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 9.06 and P/S of 0.83, while maintaining solid profitability with a 9.27% net income margin. Recent earnings have been mixed, with a beat in Q1 2026 but misses in prior quarters. The company continues to drive brand engagement through new product launches and collaborations, as highlighted by recent Comic-Con exclusives and partnerships.

The investment outlook is cautiously optimistic, supported by deep-value fundamentals and positive analyst sentiment, but tempered by recent earnings volatility and a negative net cash flow trend. Key opportunities include undervaluation relative to peers and strong brand portfolio; risks involve execution on sales growth and managing debt levels amid economic uncertainties.

Revvity Inc

RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.

The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Mattel Inc

Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.

Read more on MAT

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY